Cervical cancer is the most common malignancies in women. The majority of new cases and deaths occurred in low-and middle-income countries, which accounted for 86% and 88% of the new cases and deaths in the entire world, respectively (Bray et al., 2018). In recent years, the incidence and mortality rates of cervical cancer in women have sustained growth trends (Denny & Quinn, 2015;Shang-Ying et al., 2014). In China, 100,700 new cases (estimated incidence of 10.1-15.3 per 100,000 women) and 26,400 (estimated mortality rate of 2.59-2.76) deaths recorded in cancer registries (Shang-Ying et al., 2014;Shrestha et al., 2018). According to the 2018 data, which account for approximately 28% of the global new cases (National Health Commission of The People's Republic of China, 2019). China has a relatively high cervical cancer disease burden, especially in some rural areas (Lei et al., 2011;Shi et al., 2011).As we know, cancer has the characteristics of poor prognosis, long treatment cycles, many side effects, easy recurrence and so on, patients generally have different psychological problems. These include anxiety, dysphoria, fear, pessimism, depression, loneliness and despair (Dinkel & Herschbach, 2018;Vehling et al., 2012). The emergence of these psychological problems is often more serious than the impacts of the disease itself. Moreover, the various side effects caused by cervical cancer treatments, such as menopause symptoms, lower quality of sex life, hematuria, frequent micturition,